MRNA is expected to report earnings to rise 4.12% to -302 cents per share on May 01
Q1'25
Est.
$-3.03
Q4'24
Missed
by $0.18
Q3'24
Beat
by $1.95
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.48
The last earnings report on February 14 showed earnings per share of -291 cents, missing the estimate of -273 cents. With 12.41M shares outstanding, the current market capitalization sits at 13.03B.